Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Alx Oncology Holdings Inc shares valued at $76,892 were purchased by Lettmann Jason on Sep 17 ’25. At $1.08 per share, Lettmann Jason acquired 71,163 shares. The insider’s holdings grew to 305,121 shares worth approximately $0.42 million following the completion of this transaction.
Also, Lettmann Jason purchased 21,070 shares, netting a total of over 22,461 in proceeds. Following the buying of shares at $1.07 each, the insider now holds 233,958 shares.
Before that, Shantharam Harish had added 75,000 shares to its account. In a trade valued at $58,402, the Chief Financial Officer bought Alx Oncology Holdings Inc shares for $0.78 each. Upon closing the transaction, the insider’s holdings increased to 75,000 shares, worth approximately $0.1 million.
As published in their initiating research note from Jefferies on November 13, 2025, Alx Oncology Holdings Inc [ALXO] has been a Buy and the price target has been revised to $4. Analysts at Jefferies upgraded the stock from ‘”a Hold”‘ to ‘”a Buy”‘ outlook in a report released in early March. As of December 19, 2024, Jefferies has decreased its “Buy” rating to a “Hold” for ALXO. Earlier on March 08, 2024, Stifel downgraded its rating. Their new recommendation was “a Hold” for ALXO stock which previously was a “a Buy”.
Analyzing ALXO Stock Performance
On last trading session, Alx Oncology Holdings Inc [NASDAQ: ALXO] plunged -4.83% to $1.38. The stock’s lowest price that day was $1.35, but it reached a high of $1.47 in the same session. During the last five days, there has been a drop of approximately -6.12%. Over the course of the year, Alx Oncology Holdings Inc shares have dropped approximately -2.13%. Shares of the company reached a 52-week high of $2.2700 on 10/06/25 and a 52-week low of $0.4040 on 06/27/25.
Support And Resistance Levels for Alx Oncology Holdings Inc (ALXO)
According to the 24-hour chart, there is a support level at 1.3300, which, if violated, would cause prices to drop to 1.2800. In the upper region, resistance lies at 1.4500. The next price resistance is at 1.5200. RSI (Relative Strength Index) is 46.72 on the 14-day chart, showing neutral technical sentiment.
Is Alx Oncology Holdings Inc subject to short interest?
Stocks of Alx Oncology Holdings Inc saw a sharp steep in short interest on 2025-11-14 dropping by 80021.0 shares to 1.78 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 1.86 million shares. A decline of -4.49% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.41 of the overall float, the days-to-cover ratio (short ratio) decline to 4.41.
Which companies own the most shares of Alx Oncology Holdings Inc (ALXO)?
In terms of Alx Oncology Holdings Inc share price expectations, FactSet research, analysts set an average price target of 23 in the next 12 months, up nearly 1486.21% from the previous closing price of $1.45. Analysts anticipate Alx Oncology Holdings Inc stock to reach 38 by 2025, with the lowest price target being 1.5. In spite of this, 5 analysts ranked Alx Oncology Holdings Inc stock as Buy at the end of 2025. On December 08, 2023, Jefferies assigned a price target of “a Buy” to the stock and upgraded coverage with a $18.
